Evaluation of bleeding-related episodes in patients with immune thrombocytopenia (ITP) receiving romiplostim or medical standard of care

International Journal of Hematology, 05/09/2012

Romiplostim treatment provided greater reductions in all bleeding–related episodes (BREs), as well as BREs involving Ig rescue medications, than did standard of care (SOC).

Print Article Summary Cat 2 CME Report